UK markets closed

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6200+0.1200 (+4.80%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-28,452
-28,452
-23,210
-73,329
-255,568
Depreciation & amortisation
0
0
72
109
341
Stock-based compensation
3,305
3,305
4,297
8,080
18,100
Change in working capital
60
60
2,277
4,776
-40,331
Accounts receivable
405
405
11,210
7,709
-17,138
Inventory
0
0
97
113
-6,048
Accounts payable
-559
-559
-8,681
-2,675
-
Other working capital
-25,341
-25,341
-29,200
-56,367
-137,195
Other non-cash items
-
-
-
2,472
84,072
Net cash provided by operating activities
-25,341
-25,341
-29,200
-56,367
-137,082
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-113
Purchases of investments
-62,354
-62,354
0
-
0
Sales/maturities of investments
-
-
0
1,027
50,579
Net cash used for investing activities
-57,354
-57,354
15,667
1,027
89,107
Cash flows from financing activities
Debt repayment
-
-
0
-36,432
0
Common stock issued
82,821
82,821
1,470
75,981
61,639
Common stock repurchased
-360
-360
-
-
-
Other financing activities
-
-
-
-294
-141
Net cash used provided by (used for) financing activities
82,394
82,394
1,653
39,777
61,808
Net change in cash
-301
-301
-11,880
-15,563
13,833
Cash at beginning of period
30,975
30,975
42,855
58,418
44,584
Cash at end of period
30,674
30,674
30,975
42,855
58,418
Free cash flow
Operating cash flow
-25,341
-25,341
-29,200
-56,367
-137,082
Capital expenditure
-
-
-
-
-113
Free cash flow
-25,341
-25,341
-29,200
-56,367
-137,195